Clopra and Carbatrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopra (metoclopramide hydrochloride) and Carbatrol (carbamazepine). Common drug interactions include blood cholesterol increased among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Clopra and Carbatrol. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,430 Clopra users. Check the latest studies of Clopra.

What is Carbatrol?

Carbatrol has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 1,979 Carbatrol users. Check the latest studies of Carbatrol.

On Jul, 15, 2026

15 people who take Clopra and Carbatrol together, and have interactions are studied.

What are the common drug interactions of Clopra and Carbatrol, by gender? *:

female:

Blood cholesterol increased
Blood triglycerides increased
Obesity (having too much body fat)
Type 2 diabetes mellitus

male:

Cardiac arrest
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Skin fibrosis (fibrous tissue formation on skin)
Skin induration (an abnormally hard spot or area on the skin)
Skin tightness
Subcutaneous nodule
Xerosis (abnormal dryness of the skin or mucus membranes)
Muscle contracture (a permanent shortening of a muscle)
Pain
Pruritus (severe itching of the skin)

What are the common drug interactions of Clopra and Carbatrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Cardiac arrest
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Endocardial fibrosis (cardiac fibrosis refers to an abnormal thickening of the heart valves)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Joint contracture (a permanent shortening of a muscle or joint)
Metaplasia (change in the type of adult cells in a tissue to a form abnormal for that tissue)
Mobility decreased (ability to move is reduced)
Myocardial fibrosis (a condition in which the heart's muscle cells are impaired)
Pain in extremity
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)

20-29:

n/a

30-39:

n/a

40-49:

Blood cholesterol increased
Blood triglycerides increased
Obesity (having too much body fat)
Type 2 diabetes mellitus

50-59:

Blood pressure decreased
Dizziness
Flushing (the warm, red condition of human skin)
Infusion related reaction
Pruritus (severe itching of the skin)
Rash

60+:

n/a

What are the existing conditions these people have? *

Joint Pain: 9 people, 60.00%
Catheter Related Complication: 8 people, 53.33%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 6 people, 40.00%
Nuclear Magnetic Resonance Imaging Brain: 4 people, 26.67%
Anaemia (lack of blood): 4 people, 26.67%
Renal Osteodystrophy (a bone disease occurs when the kidneys fail to maintain the proper levels of calcium and phosphorus in the blood): 3 people, 20.00%
Blood Calcium Decreased: 3 people, 20.00%
Chronic Renal Failure (kidney failure): 3 people, 20.00%
Headache (pain in head): 3 people, 20.00%
High Blood Pressure: 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and Carbatrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously